Immunosenescence: A systems-level overview of immune cell biology and strategies for improving vaccine responses
- PMID: 31201918
- PMCID: PMC6849399
- DOI: 10.1016/j.exger.2019.110632
Immunosenescence: A systems-level overview of immune cell biology and strategies for improving vaccine responses
Abstract
Immunosenescence contributes to a decreased capacity of the immune system to respond effectively to infections or vaccines in the elderly. The full extent of the biological changes that lead to immunosenescence are unknown, but numerous cell types involved in innate and adaptive immunity exhibit altered phenotypes and function as a result of aging. These manifestations of immunosenescence at the cellular level are mediated by dysregulation at the genetic level, and changes throughout the immune system are, in turn, propagated by numerous cellular interactions. Environmental factors, such as nutrition, also exert significant influence on the immune system during aging. While the mechanisms that govern the onset of immunosenescence are complex, systems biology approaches allow for the identification of individual contributions from each component within the system as a whole. Although there is still much to learn regarding immunosenescence, systems-level studies of vaccine responses have been highly informative and will guide the development of new vaccine candidates, novel adjuvant formulations, and immunotherapeutic drugs to improve vaccine responses among the aging population.
Keywords: Adjuvants; Aging; Immunity; Immunosenescence; Senolytics; Systems biology; Vaccinology.
Copyright © 2019. Published by Elsevier Inc.
Conflict of interest statement
COMPETING INTERESTS
Dr. Poland is the chair of a Safety Evaluation Committee for novel investigational vaccine trials being conducted by Merck Research Laboratories. Dr. Poland offers consultative advice on vaccine development to Merck & Co. Inc., Avianax, Adjuvance, Valneva, Medicago, Sanofi Pasteur, GlaxoSmithKline, and Emergent Biosolutions. Drs. Poland and Ovsyannikova hold patents related to vaccinia and measles peptide vaccines. Dr. Kennedy holds a patent related to vaccinia peptide vaccines. Dr. Kennedy has received research funding from Merck Research Laboratories to study waning immune responses to mumps vaccine. These activities have been reviewed by the Mayo Clinic Conflict of Interest Review Board and are conducted in compliance with Mayo Clinic Conflict of Interest policies. All other authors declare no competing interests.
Figures
Similar articles
-
Immunosenescence and vaccine failure in the elderly.Aging Clin Exp Res. 2009 Jun;21(3):201-9. doi: 10.1007/BF03324904. Aging Clin Exp Res. 2009. PMID: 19571643 Review.
-
Targeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly.Front Immunol. 2020 Oct 14;11:583019. doi: 10.3389/fimmu.2020.583019. eCollection 2020. Front Immunol. 2020. PMID: 33178213 Free PMC article. Review.
-
Personalized vaccinology: A review.Vaccine. 2018 Aug 28;36(36):5350-5357. doi: 10.1016/j.vaccine.2017.07.062. Epub 2017 Jul 31. Vaccine. 2018. PMID: 28774561 Free PMC article. Review.
-
Understanding the immune response to seasonal influenza vaccination in older adults: a systems biology approach.Expert Rev Vaccines. 2012 Aug;11(8):985-94. doi: 10.1586/erv.12.61. Expert Rev Vaccines. 2012. PMID: 23002979 Free PMC article. Review.
-
Rheumatoid arthritis: a role for immunosenescence?J Am Geriatr Soc. 2010 Aug;58(8):1565-75. doi: 10.1111/j.1532-5415.2010.02965.x. Epub 2010 Jul 19. J Am Geriatr Soc. 2010. PMID: 20942872 Free PMC article. Review.
Cited by
-
Interplay of calcium pyrophosphate crystals, oxidative stress, and clinical features on knee osteoarthritis severity.Clin Rheumatol. 2024 Nov 6. doi: 10.1007/s10067-024-07220-y. Online ahead of print. Clin Rheumatol. 2024. PMID: 39503904
-
The Challenge of Misleading Information: Does the Interaction between Zinc and Vitamin D Influence the Immune Response against SARS-CoV-2 in the Elderly Population?Life (Basel). 2024 Oct 8;14(10):1277. doi: 10.3390/life14101277. Life (Basel). 2024. PMID: 39459577 Free PMC article.
-
The Major Role of T Regulatory Cells in the Efficiency of Vaccination in General and Immunocompromised Populations: A Review.Vaccines (Basel). 2024 Aug 30;12(9):992. doi: 10.3390/vaccines12090992. Vaccines (Basel). 2024. PMID: 39340024 Free PMC article. Review.
-
Revolutionizing Cancer Treatment: Recent Advances in Immunotherapy.Biomedicines. 2024 Sep 23;12(9):2158. doi: 10.3390/biomedicines12092158. Biomedicines. 2024. PMID: 39335671 Free PMC article. Review.
-
Trajectories of peripheral white blood cells count around the menopause: a prospective cohort study.BMC Womens Health. 2024 Sep 11;24(1):504. doi: 10.1186/s12905-024-03344-0. BMC Womens Health. 2024. PMID: 39261797 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
